Your browser doesn't support javascript.
loading
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy.
Eschweiler, Simon; Clarke, James; Ramírez-Suástegui, Ciro; Panwar, Bharat; Madrigal, Ariel; Chee, Serena J; Karydis, Ioannis; Woo, Edwin; Alzetani, Aiman; Elsheikh, Somaia; Hanley, C J; Thomas, G J; Friedmann, Peter S; Sanchez-Elsner, Tilman; Ay, Ferhat; Ottensmeier, Christian H; Vijayanand, Pandurangan.
Afiliación
  • Eschweiler S; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Clarke J; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Ramírez-Suástegui C; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Panwar B; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Madrigal A; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Chee SJ; NIHR and CRUK Southampton Experimental Cancer Medicine Center, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Karydis I; NIHR Southampton Biomedical Research Center, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Woo E; Southampton University Hospitals NHS Foundation Trust, Southampton, UK.
  • Alzetani A; NIHR and CRUK Southampton Experimental Cancer Medicine Center, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Elsheikh S; Southampton University Hospitals NHS Foundation Trust, Southampton, UK.
  • Hanley CJ; Southampton University Hospitals NHS Foundation Trust, Southampton, UK.
  • Thomas GJ; Southampton University Hospitals NHS Foundation Trust, Southampton, UK.
  • Friedmann PS; Department of Cellular Pathology, Nottingham University Hospital, Nottingham, England.
  • Sanchez-Elsner T; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, England.
  • Ay F; NIHR and CRUK Southampton Experimental Cancer Medicine Center, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Ottensmeier CH; NIHR Southampton Biomedical Research Center, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Vijayanand P; NIHR and CRUK Southampton Experimental Cancer Medicine Center, Faculty of Medicine, University of Southampton, Southampton, UK.
Nat Immunol ; 22(8): 1052-1063, 2021 08.
Article en En | MEDLINE | ID: mdl-34168370
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_malignant_skin_melanoma Asunto principal: Linfocitos Infiltrantes de Tumor / Linfocitos T Reguladores / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Melanoma Límite: Animals / Female / Humans Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_malignant_skin_melanoma Asunto principal: Linfocitos Infiltrantes de Tumor / Linfocitos T Reguladores / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Melanoma Límite: Animals / Female / Humans Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos